Mass. Movers

Haemonetics earnings slide 46 percent

Brian Concannon is the chief executive of Haemonetics.

Yoon S. Byun/Globe Staff/File 2010

Brian Concannon is the chief executive of Haemonetics.

Haemonetics Corp. slid after it said quarterly earnings fell 46 percent. The Braintree company, which makes and sells blood-management systems, earned $9.9 million, or 19 cents per share, in the quarter ended in December, compared to $18.3 million, or 36 cents, a year earlier. Administrative and other expenses rose 41 percent; research and development costs rose about 15 percent. Haemonetics said it expects its new OrthoPat Advance system to drive fiscal 2014 growth.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of